With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2024 Earnings Call Transcript November 4, 2024Vertex Pharmaceuticals Incorporated beats earnings expectations.
Keep Reading →
November 5 - News, Transcripts
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
October 3 - Hedge Fund Investor Letters, News
In a recent episode of Mad Money, Jim Cramer offers a perspective on Nvidia and its recent market behavior on Wednesday's episode of Mad Money, presenting a straightforward analysis...
Keep Reading →
August 30 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript August 1, 2024Vertex Pharmaceuticals Incorporated misses on earnings expectations.
Keep Reading →
August 3 - News, Transcripts
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Keep Reading →
June 24 - Hedge Funds, News
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ...
Keep Reading →
June 19 - Hedge Funds, News
Venu Krishna, Head of U.S.
Keep Reading →
June 18 - Hedge Funds, News
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Keep Reading →
June 14 - Hedge Funds, News
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading...
Keep Reading →
June 3 - Hedge Funds
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Keep Reading →
May 8 - Market Movers, News
Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07.
Keep Reading →
May 7 - News, Transcripts
In this article, we discuss the 23 most profitable stocks of the last 12 months.
Keep Reading →
May 4 - Hedge Funds, News
In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
Keep Reading →
March 17 - News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
Aristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity Strategy” fourth quarter 2023 investor letter.
Keep Reading →
March 4 - Hedge Fund Investor Letters, News
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the top 5 CRISPR stocks to invest in.
Keep Reading →
February 10 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
February 9 - Hedge Fund Investor Letters, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.
Keep Reading →
February 6 - News, Transcripts
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
Keep Reading →
January 22 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this piece, we will take a look at the 12 best low beta stocks to buy.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
Operator: Good day and welcome to the Vertex Pharmaceuticals Third Quarter 2023 Conference Call. All participants will be in a listen only mode.
Keep Reading →
November 7 - News, Transcripts
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this article, we shall cover the top 30 oncology companies in the world.
Keep Reading →
October 13 - Business, Hedge Funds, Lists, News
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” second quarter 2023 investor letter.
Keep Reading →
September 20 - Hedge Fund Investor Letters, News
Operator: Good afternoon and welcome to the Vertex Pharmaceuticals Second Quarter 2023 Earnings Conference Call.
Keep Reading →
August 2 - News, Transcripts
In this article, we discuss 5 DNA stocks that billionaires love.
Keep Reading →
June 14 - Hedge Funds, News
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
May 18 - Hedge Fund Investor Letters, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals First Quarter 2023 Conference Call. All participants will be in a listen-only mode.
Keep Reading →
May 4 - News, Transcripts
In this article, we take a look at 27 largest biotech companies in the US.
Keep Reading →
April 29 - Lists, News
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
Keep Reading →
April 20 - Hedge Funds, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter and Full Year 2022 Conference Call. All participants will be in a listen-only mode.
Keep Reading →
February 9 - News, Transcripts
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News
Below we take a look at Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we discuss the 5 biotech stocks with the biggest upside.
Keep Reading →
December 13 - Hedge Funds, News
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
November 16 - Hedge Fund Investor Letters, News
ClearBridge Investments, an investment management company, released its “ClearBridge Aggressive Growth Strategy” third quarter 2022 investor letter.
Keep Reading →
November 8 - Hedge Fund Investor Letters, News
All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc.
Keep Reading →
October 28 - News
